ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 185 filers reported holding ASCENDIS PHARMA A/S in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $319,593 | +9423.0% | 3,413 | -87.6% | 0.00% | -95.5% |
| Q4 2022 | $3,356 | -99.9% | 27,476 | -14.0% | 0.07% | -7.0% |
| Q3 2022 | $3,297,000 | +70.4% | 31,932 | +53.4% | 0.07% | +39.2% |
| Q2 2022 | $1,935,000 | +72.9% | 20,814 | +144.6% | 0.05% | +142.9% |
| Q2 2021 | $1,119,000 | -54.0% | 8,509 | -54.9% | 0.02% | -57.1% |
| Q1 2021 | $2,431,000 | +13.2% | 18,862 | +46.5% | 0.05% | -19.7% |
| Q4 2020 | $2,147,000 | +196.1% | 12,872 | +173.9% | 0.06% | +90.6% |
| Q3 2020 | $725,000 | +56.9% | 4,700 | +50.4% | 0.03% | +39.1% |
| Q2 2020 | $462,000 | -39.7% | 3,125 | -73.3% | 0.02% | -8.0% |
| Q1 2018 | $766,000 | +154.5% | 11,705 | +55.9% | 0.02% | +212.5% |
| Q4 2017 | $301,000 | +40.0% | 7,510 | +26.9% | 0.01% | +60.0% |
| Q3 2017 | $215,000 | – | 5,918 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |